Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma-Reference-Cited by-同舟云学术

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

Published:2005 Issue:4 Volume:117 Page:596-604
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kruit Wim H.J.,van Ojik Heidi H.,Brichard Vincent G.,Escudier Bernard,Dorval Thierry,Dréno Brigitte,Patel Poulam,van Baren Nicolas,Avril Marie-Françoise,Piperno Sophie,Khammari Amir,Stas Marguerite,Ritter Gerd,Lethé Bernard,Godelaine Danièle,Brasseur Francis,Zhang Yi,van der Bruggen Pierre,Boon Thierry,Eggermont Alexander M.M.,Marchand Marie

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

2. T cell defined tumor antigens

3. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

4. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

5. Biological and clinical developments in melanoma vaccines

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants;Reference Module in Biomedical Sciences;2024

2. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis;Journal for ImmunoTherapy of Cancer;2023-12

3. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a- and Siglece-based vaccination induces anti-tumor immunity and inhibits metastasis;2023-05-10

4. Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity;Molecular Immunology;2022-10

5. Development of Pharmaceutical Nanomedicines: From the Bench to the Market;Pharmaceutics;2022-01-03